跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
clotting factor VIII
首页
药物
clotting factor VIII
clotting factor VIII
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
OPTIMIZED HUMAN CLOTTING FACTOR VIII GENE EXPRESSION CASSETTES AND THEIR USE
EP 3611186 A1
申请人: UNIV NORTH CAROLINA CHAPEL HILL
优先权: 2015
CN
EP
US
WO
9 件公开
Optimised coding sequence and promoter
US 9393323 B2
申请人: NATHWANI AMIT
优先权: 2009
EP
US
7 件公开
Liver specific transcriptional enhancer
US 7179903 B2
申请人: CELL GENESYS INC
优先权: 2002
US
6 件公开
COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING TRANSFERRIN
EP 3737762 A1
申请人: CRISPR THERAPEUTICS AG
优先权: 2018
EP
US
WO
5 件公开
CLOTTING FACTOR PREPARATIONS FOR DELIVERY INTO TISSUE OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
EP 3962516 A4
申请人: RANI THERAPEUTICS LLC
优先权: 2019
CN
EP
US
WO
4 件公开
Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
US 9663553 B2
申请人: HEMARUS THERAPEUTICS LTD
优先权: 2014
EP
US
WO
4 件公开
METHOD AND APPARATUS FOR PROVIDING A PHARMACOKINETIC DRUG DOSING REGIMENT
EP 4343774 A3
申请人: TAKEDA PHARMACEUTICALS CO
优先权: 2016
EP
US
4 件公开
Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
US 2005221414 A1
申请人: VARADI KATALIN
优先权: 2004
US
4 件公开
Modified plasma clotting factor VIII and method of use thereof
US 11795207 B2
申请人: AAVNERGENE INC
优先权: 2021
US
4 件公开
COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING FIBRINOGEN-ALPHA
EP 3752616 A1
申请人: CRISPR THERAPEUTICS AG
优先权: 2018
EP
US
WO
3 件公开
第 1 / 3 页
上一页
下一页
药物
反馈